• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, June 27, 2022
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

MICROB-PREDICT — €15 million EU funded microbiome research project kicks off

Bioengineer by Bioengineer
February 1, 2019
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Developing personalised targets for treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF)

Barcelona, Spain, 1 February 2019 – An EU Horizon 2020-financed project investigating methods to better understand the role of the microbiome to help stratify patient health care and treatment of decompensated cirrhosis and ACLF officially commenced last month. The innovative endeavour, known as MICROB-PREDICT, involves a 22-member multinational and multidisciplinary consortium of world-leading microbiome specialists, clinical experts, and patient organisations. MICROB-PREDICT is an acronym for “MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response”. Cirrhosis is the cause of 1.2 million deaths worldwide annually . It is estimated that less than 10% of ongoing studies in the field are focused on decompensated cirrhosis and ACLF . As a result, treatment options for patients are lacking considerably.

MICROB-PREDICT & the gut-liver-axis

The microbiome plays a critical role in the development and severity of cirrhosis, which is a major cause of morbidity and mortality worldwide. “One of our aims is to find the microbiome signatures of decompensation of cirrhosis and predict the development of ACLF. Moreover, this project will develop point-of-care devices to predict the response to specific treatments in these patients. The project has the potential to change the clinical practice towards more personalized medicine,” says Prof. Jonel Trebicka, scientific coordinator of the MICROB-PREDICT consortium.

Potential for new treatment strategies

The project will base the development of biomarkers on high-quality data from three existing EU-funded projects (GALAXY, LIVERHOPE, and PREDICT). The knowledge gained throughout the 75 month project will contribute to the development of improved and potentially personalized therapies for patients suffering from cirrhosis and ACLF. A basic website about the project is already online (http://www.microb-predict.eu), and a more extensive project website will be launched in the coming months.

The 22 partners in the MICROB-PREDICT consortium coordinated by EF-CLIF are:

  • Academisch Ziekenhuis Leiden (Leiden University Medical Center) (LUMC)

  • Biobyte Solutions GmbH (Biobyte)

  • Commissariat à l’Energie Atomique et aux Energies Alternatives (CEA)

  • concentris research management GmbH (concentris)

  • Debreceni Egyetem (University of Debrecen) (UNIDEB)

  • European Association For The Study of the Liver (EASL)

  • European Foundation For The Study of Chronic Liver Failure (EF-CLIF)

  • European Liver Patients Association (ELPA)

  • European Molecular Biology Laboratory (EMBL)

  • Fundacio Clinic Per A La Recerca Biomedica (FCRB)

  • Fundacio Institut Catala De Nanociencia i Nanotecnologia (ICN2)

  • Institut National De La Recherche Agronomique (INRA)

  • Johann Wolfgang Goethe-Universität Frankfurt Am Main (GUF)

  • Katholieke Universiteit Leuven (KU Leuven)

  • King’s College London (KCL)

  • Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. (MPG)

  • Odense Universitetshospital (OUH)

  • Universitat de Barcelona (UB)

  • Universitetet I Oslo (UiO)

  • University College London (UCL)

  • University of Copenhagen (UCPH)

  • Vaiomer SAS (Vaiomer)

###

1 – Murray CJ, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D, et al (2013). The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA; 310: 591-608.

2 – Zutshi Y (2015). Liver Disease Treatments: The Global Market. BBC Research; PHM057C.

Media Contact
Margaret Walker
[email protected]
44-077-471-21175
https://mailchi.mp/easloffice/press-release-microbpredict-01022019

Tags: GastroenterologyInternal MedicineLiverMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Novel sewage treatment

Novel sewage treatment system removes up to 70% of nitrogen that would otherwise be discarded into nature

June 24, 2022
Maria Argos

Arsenic in private well water contributes to low birth weight even at low levels

June 24, 2022

Oral antiviral drug effective against respiratory syncytial virus (RSV) identified by Biomedical Sciences researchers

June 24, 2022

Stop for migration!

June 24, 2022
Please login to join discussion

POPULAR NEWS

  • Pacific whiting

    Oregon State University research finds evidence to suggest Pacific whiting skin has anti-aging properties that prevent wrinkles

    37 shares
    Share 15 Tweet 9
  • University of Miami Rosenstiel School selected for National ‘Reefense’ Initiative focusing on Florida and the Caribbean

    35 shares
    Share 14 Tweet 9
  • Saving the Mekong delta from drowning

    37 shares
    Share 15 Tweet 9
  • Sharks may be closer to the city than you think, new study finds

    34 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

VehiclesViolence/CriminalsUrbanizationUniversity of WashingtonWeather/StormsVaccinesVirologyUrogenital SystemZoology/Veterinary ScienceVaccineVirusWeaponry

Recent Posts

  • USDA-ARS releases genome of the voracious desert locust
  • Repairing nature with DNA technology
  • The Sussex researchers who used international collaboration and 3D printing to stem PPE shortages in Nigeria
  • Predicting the future: A quick, easy scan can reveal late-life dementia risk
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....